Calvin Scott Recalls Phentermine Tablets Due to Packaging Defect
Calvin Scott & Company is recalling specific lots of Phentermine HCL 37.5 mg tablets because they were repackaged in transparent pouches, violating light-sensitivity requirements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible adverse health consequences. The hazard is a packaging defect (light sensitivity) rather than a direct contamination or mislabeling of an allergen, fitting the Moderate severity criteria for minor labeling/packaging errors or low-risk contamination.
Plain-English summary
Calvin Scott & Company, Inc. is recalling specific lots of Phentermine HCL Blue Speckled tablets, 37.5 mg. The affected products are packaged in 14-count and 28-count bags and are distributed nationwide within the United States. The recall involves multiple lot numbers with expiration dates ranging from August 2020 to February 2021.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the light-sensitive drug products were repackaged in transparent or partially transparent pouches, which does not meet the required packaging standards for light-sensitive medications.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed in the recall notice. If the product matches the recalled lots, it should be returned to the pharmacy or distributor for disposal or replacement. No specific adverse health events are reported in the source text.
The recalled product
- Product
- Phentermine HCL Blue Speckled tablets, 37.5 mg, packaged in a) 14-count bags (NDC 10702-0025-10) and b) 28-count bags (NDC 10702-0025-10), Rx Only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940.
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot #: a) 19271
- Exp. Date 10/20 b) 19206
- 19209B
- Exp. Date 08/20
- 19229
- Exp. Date 10/20
- 19255
- Exp. Date 09/20
- 19271
- 19301
- 19327
- Exp. Date 11/20
- 19336
- Exp. 12/20
- 20012
- Exp. Date 1/21
- 20045
- Exp. Date 2/21.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12